John V. Heymach, Noboru Yamamoto, Nicolas Girard, Gerrina Ruiter, Egbert F. Smit, David Planchard, Ernest Nadal, Yi-Long Wu, Jon Zugazagoitia, Hai-Yan Tu, Christina S. Baik, Kiyotaka Yoh, Ross A. Soo, Yanqiu Zhao, Joshua K. Sabari, Martin Wermke, Matthias Scheffler, Myung-Ju Ahn, Kristie Fernamberg, Lukas Schroeter, Behbood Sadrolhefazi, Claus Thamer, Sabina Eigenbrod-Giese, Sanjay Popat. "First-Line Zongertinib in Advanced
                    <i>HER2</i>
                    -Mutant Non–Small-Cell Lung Cancer." New England Journal of Medicine (2026). https://doi.org/10.1056/nejmoa2516969